Dengue virus pathogenesis: An integrated view

Clinical Microbiology Reviews

Volumn 22, Issue 4, 2009, Pages 564-581

  Martina, Byron E E ^a   Koraka, Penelope ^a   Osterhaus, Albert D M E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; DENGUE; DENGUE VIRUS; HUMAN; NONHUMAN; REVIEW; VIRUS IMMUNITY; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

DENGUE; DENGUE VIRUS; HUMANS;

DENGUE VIRUS;

EID: 70449094069     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00035-09     Document Type: Review

References (276)

1. Acioli-Santos, B., L. Segat, R. Dhalia, C. A. Brito, U. M. Braga-Neto, E. T. Marques, and S. Crovella. 2008. MBL2 gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype. Hum. Immunol. 69:122-128.
2. Agarwal, R., U. C. Chaturvedi, A. Misra, R. Mukerjee, S. Kapoor, R. Nagar, R. Tandon, and A. Mathur. 1998. Production of cytotoxic factor by peripheral blood mononuclear cells (PBMC) in patients with dengue haemorrhagic fever. Clin. Exp. Immunol. 112:477-481.
3. An, J., D. S. Zhou, J. L. Zhang, H. Morida, J. L. Wang, and K. Yasui. 2004. Dengue-specific CD8+ T cells have both protective and pathogenic roles in dengue virus infection. Immunol. Lett. 95:167-174.
4. Andriopoulou, P., P. Navarro, A. Zanetti, M. G. Lampugnani, and E. Dejana. 1999. Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler. Thromb. Vasc. Biol. 19:2286-2297.
5. Aoki, S., M. Osada, M. Kaneko, Y. Ozaki, and Y. Yatomi. 2007. Fluid shear stress enhances the sphingosine 1-phosphate responses in cell-cell interactions between platelets and endothelial cells. Biochem. Biophys. Res. Commun. 358:1054-1057.
6. Atrasheuskaya, A., P. Petzelbauer, T. M. Fredeking, and G. Ignatyev. 2003. Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol. Med. Microbiol. 35:33-42.
7. Avirutnan, P., P. Malasit, B. Seliger, S. Bhakdi, and M. Husmann. 1998. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J. Immunol. 161:6338-6346. (Pubitemid 28536010)
8. Avirutnan, P., N. Punyadee, S. Noisakran, C. Komoltri, S. Thiemmeca, K. Auethavornanan, A. Jairungsri, R. Kanlaya, N. Tangthawornchaikul, C. Puttikhunt, S. N. Pattanakitsakul, P. T. Yenchitsomanus, J. Mongkolsapaya, W. Kasinrerk, N. Sittisombut, M. Husmann, M. Blettner, S. Vasanawathana, S. Bhakdi, and P. Malasit. 2006. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J. Infect. Dis. 193:1078-1088.
9. Avirutnan, P., L. Zhang, N. Punyadee, A. Manuyakorn, C. Puttikhunt, W. Kasinrerk, P. Malasit, J. P. Atkinson, and M. S. Diamond. 2007. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog. 3:e183. (Pubitemid 350291614)
10. Azeredo, E. L., S. M. Zagne, M. A. Santiago, A. S. Gouvea, A. A. Santana, P. C. Neves-Souza, R. M. Nogueira, M. P. Miagostovich, and C. F. Kubelka. 2001. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 204:494-507.
11. Azizan, A., J. Sweat, C. Espino, J. Gemmer, L. Stark, and D. Kazanis. 2006. Differential proinflammatory and angiogenesis-specific cytokine production in human pulmonary endothelial cells, HPMEC-ST1.6R infected with dengue-2 and dengue-3 virus. J. Virol. Methods 138:211-217. (Pubitemid 44633458)
12. Balasubramanian, S., L. Janakiraman, S. S. Kumar, S. Muralinath, and S. Shivbalan. 2006. A reappraisal of the criteria to diagnose plasma leakage in dengue hemorrhagic fever. Indian Pediatr. 43:334-339.
13. Balsitis, S. J., J. Coloma, G. Castro, A. Alava, D. Flores, J. H. McKerrow, P. R. Beatty, and E. Harris. 2009. Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am. J. Trop. Med. Hyg. 80:416-424.
14. Basilio-de-Oliveira, C. A., G. R. Aguiar, M. S. Baldanza, O. M. Barth, W. A. Eyer-Silva, and M. V. Paes. 2005. Pathologic study of a fatal case of dengue-3 virus infection in Rio de Janeiro, Brazil. Braz. J. Infect. Dis. 9:341-347.
15. Basu, A., and U. C. Chaturvedi. 2008. Vascular endothelium: the battlefield of dengue viruses. FEMS Immunol. Med. Microbiol. 53:287-299.
16. Bethell, D. B., J. Gamble, P. L. Pham, M. D. Nguyen, T. H. Tran, T. H. Ha, T. N. Tran, T. H. Dong, I. B. Gartside, N. J. White, and N. P. Day. 2001. Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clin. Infect. Dis. 32:243-253.
17. Bhamarapravati, N., P. Tuchinda, and V. Boonyapaknavik. 1967. Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann. Trop. Med. Parasitol. 61:500-510.
18. Blackley, S., Z. Kou, H. Chen, M. Quinn, R. C. Rose, J. J. Schlesinger, M. Coppage, and X. Jin. 2007. Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J. Virol. 81:13325-13334. (Pubitemid 350247829)
19. Bonner, S. M., and M. A. O'Sullivan. 1998. Endothelial cell monolayers as a model system to investigate dengue shock syndrome. J. Virol. Methods 71:159-167.
20. Boonnak, K., B. M. Slike, T. H. Burgess, R. M. Mason, S. J. Wu, P. Sun, K. Porter, I. F. Rudiman, D. Yuwono, P. Puthavathana, and M. A. Marovich. 2008. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J. Virol. 82:3939-3951.
21. Boonpucknavig, S., V. Boonpucknavig, N. Bhamarapravati, and S. Nimmannitya. 1979. Immunofluorescence study of skin rash in patients with dengue hemorrhagic fever. Arch. Pathol. Lab. Med. 103:463-466.
22. Bosch, I., K. Xhaja, L. Estevez, G. Raines, H. Melichar, R. V. Warke, M. V. Fournier, F. A. Ennis, and A. L. Rothman. 2002. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J. Virol. 76:5588-5597. (Pubitemid 34517909)
23. Bozza, F. A., O. G. Cruz, S. M. Zagne, E. L. Azeredo, R. M. Nogueira, E. F. Assis, P. T. Bozza, and C. F. Kubelka. 2008. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC. Infect. Dis. 8:86.
24. Bracken, M. B. 2005. Genomic epidemiology of complex disease: the need for an electronic evidence-based approach to research synthesis. Am. J. Epidemiol. 162:297-301.
25. Burke, D. S., and S. Kliks. 2006. Antibody-dependent enhancement in dengue virus infections. J. Infect. Dis. 193:601-603. (Author reply, 193:603-604.)
26. Butthep, P., S. Chunhakan, K. Tangnararatchakit, S. Yoksan, K. Pattanapanyasat, and A. Chuansumrit. 2006. Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome. Pediatr. Infect. Dis. J. 25:894-897.
27. Cardier, J. E., V. Balogh, C. Perez-Silva, E. Romano, B. Rivas, N. Bosch, and A. L. Rothman. 2006. Relationship of thrombopoietin and interleukin- 11 levels to thrombocytopenia associated with dengue disease. Cytokine 34:155-160.
28. Cardier, J. E., E. Marino, E. Romano, P. Taylor, F. Liprandi, N. Bosch, and A. L. Rothman. 2005. Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-alpha in endothelial cell damage in dengue. Cytokine 30:359-365.
29. Cardier, J. E., B. Rivas, E. Romano, A. L. Rothman, C. Perez-Perez, M. Ochoa, A. M. Caceres, M. Cardier, N. Guevara, and R. Giovannetti. 2006. Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells. Endothelium 13:335-340.
30. Carlos, C. C., K. Oishi, M. T. Cinco, C. A. Mapua, S. Inoue, D. J. Cruz, M. A. Pancho, C. Z. Tanig, R. R. Matias, K. Morita, F. F. Natividad, A. Igarashi, and T. Nagatake. 2005. Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines. Am. J. Trop. Med. Hyg. 73:435-440.
31. Casadevall, A., and L. A. Pirofski. 1999. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect. Immun. 67:3703-3713.
32. Chakravarti, A., and R. Kumaria. 2006. Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak. Indian J. Med. Res. 123:25-30.
33. Chang, H. H., H. F. Shyu, Y. M. Wang, D. S. Sun, R. H. Shyu, S. S. Tang, and Y. S. Huang. 2002. Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen. J. Infect. Dis. 186:743-751.
34. Chanthavanich, P., C. Luxemburger, C. Sirivichayakul, K. Lapphra, K. Pengsaa, S. Yoksan, A. Sabchareon, and J. Lang. 2006. Immune response and occurrence of dengue infection in Thai children three to eight years after vaccination with live attenuated tetravalent dengue vaccine. Am. J. Trop. Med. Hyg. 75:26-28.
35. Chao, Y. C., C. S. Huang, C. N. Lee, S. Y. Chang, C. C. King, and C. L. Kao. 2008. Higher infection of dengue virus serotype 2 in human monocytes of patients with G6PD deficiency. PLoS One 3:e1557.
36. Chareonsirisuthigul, T., S. Kalayanarooj, and S. Ubol. 2007. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J. Gen. Virol. 88:365-375.
37. Chaturvedi, U. C., E. A. Elbishbishi, R. Agarwal, and A. S. Mustafa. 2001. Cytotoxic factor-autoantibodies: possible role in the pathogenesis of dengue haemorrhagic fever. FEMS Immunol. Med. Microbiol. 30:181-186.
38. Chau, T. N., N. T. Quyen, T. T. Thuy, N. M. Tuan, D. M. Hoang, N. T. Dung, B. Lien le, N. T. Quy, N. T. Hieu, L. T. Hieu, T. T. Hien, N. T. Hung, J. Farrar, and C. P. Simmons. 2008. Dengue in Vietnamese infants - xresults of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. J. Infect. Dis. 198:516-524.
39. Chen, H. C., F. M. Hofman, J. T. Kung, Y. D. Lin, and B. A. Wu-Hsieh. 2007. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J. Virol. 81:5518-5526.
40. Chen, H. D., A. E. Fraire, I. Joris, M. A. Brehm, R. M. Welsh, and L. K. Selin. 2001. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat. Immunol. 2:1067-1076.
41. Chen, H. D., A. E. Fraire, I. Joris, R. M. Welsh, and L. K. Selin. 2003. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am. J. Pathol. 163:1341-1355.
42. Chen, H. L., S. R. Lin, H. F. Liu, C. C. King, S. C. Hsieh, and W. K. Wang. 2008. Evolution of dengue virus type 2 during two consecutive outbreaks with an increase in severity in southern Taiwan in 2001-2002. Am. J. Trop. Med. Hyg. 79:495-505.
43. Chen, J. P., and T. M. Cosgriff. 2000. Hemorrhagic fever virus-induced changes in hemostasis and vascular biology. Blood Coagul. Fibrinolysis 11:461-483.
44. Chen, L. C., H. Y. Lei, C. C. Liu, S. C. Shiesh, S. H. Chen, H. S. Liu, Y. S. Lin, S. T. Wang, H. W. Shyu, and T. M. Yeh. 2006. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am. J. Trop. Med. Hyg. 74:142-147.
45. Chen, R. F., L. Wang, J. T. Cheng, H. Chuang, J. C. Chang, J. W. Liu, I. C. Lin, and K. D. Yang. 2009. Combination of CTLA-4 and TGFbeta1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak. Clin. Immunol. 131:404-409.
46. Chen, R. F., K. D. Yang, L. Wang, J. W. Liu, C. C. Chiu, and J. T. Cheng. 2007. Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency. Trans. R. Soc. Trop. Med. Hyg. 101:1106-1113.
47. Chen, Y. C., and S. Y. Wang. 2002. Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J. Virol. 76:9877-9887.
48. Choi, G., M. J. Schultz, M. Levi, and T. van der Poll. 2006. The relationship between inflammation and the coagulation system. Swiss Med. Wkly. 136: 139-144.
49. Chungue, E., L. Poli, C. Roche, P. Gestas, P. Glaziou, and L. J. Markoff.s. 1994. Correlation between detection of plasminogen cross-reactive antibodies and hemorrhage in dengue virus infection. J. Infect. Dis. 170:1304-1307.
50. Churdboonchart, V., N. Bhamarapravati, and P. Futrakul. 1983. Crossed immunoelectrophoresis for the detection of split products of the third complement in dengue hemorrhagic fever. I. Observations in patients' plasma. Am. J. Trop. Med. Hyg. 32:569-576.
51. Cologna, R., and R. Rico-Hesse. 2003. American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J. Virol. 77:3929-3938. (Pubitemid 36350934)
52. Cornberg, M., A. T. Chen, L. A. Wilkinson, M. A. Brehm, S. K. Kim, C. Calcagno, D. Ghersi, R. Puzone, F. Celada, R. M. Welsh, and L. K. Selin. 2006. Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity. J. Clin. Investig. 116:1443-1456.
53. Couvelard, A., P. Marianneau, C. Bedel, M. T. Drouet, F. Vachon, D. Henin, and V. Deubel. 1999. Report of a fatal case of dengue infection with hepatitis: demonstration of dengue antigens in hepatocytes and liver apoptosis. Hum. Pathol. 30:1106-1110.
54. Dejana, E., E. Tournier-Lasserve, and B. M. Weinstein. 2009. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev. Cell 16:209-221.
55. de Jong, M. D., C. P. Simmons, T. T. Thanh, V. M. Hien, G. J. Smith, T. N. Chau, D. M. Hoang, N. V. Chau, T. H. Khanh, V. C. Dong, P. T. Qui, B. V. Cam, Q. Ha do, Y. Guan, J. S. Peiris, N. T. Chinh, T. T. Hien, and J. Farrar. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12:1203-1207.
56. de la C Sierra, B., G. Garcia, A. B. Perez, L. Morier, M. Alvarez, G. Kouri, and M. G. Guzman. 2006. Ethnicity and difference in dengue virus-specific memory T cell responses in Cuban individuals. Viral Immunol. 19:662-668.
57. de la C Sierra, B., G. Kouri, and M. G. Guzman. 2007. Race: a risk factor for dengue hemorrhagic fever. Arch. Virol. 152:533-542.
58. de Macedo, F. C., A. F. Nicol, L. D. Cooper, M. Yearsley, A. R. Pires, and G. J. Nuovo. 2006. Histologic, viral, and molecular correlates of dengue fever infection of the liver using highly sensitive immunohistochemistry. Diagn. Mol. Pathol. 15:223-228.
59. de Souza, L. J., R. M. Nogueira, L. C. Soares, C. E. Soares, B. F. Ribas, F. P. Alves, F. R. Vieira, and F. E. Pessanha. 2007. The impact of dengue on liver function as evaluated by aminotransferase levels. Braz. J. Infect. Dis. 11: 407-410.
60. Dewi, B. E., T. Takasaki, and I. Kurane. 2004. In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J. Virol. Methods 121:171-180.
61. Diamond, M. S., D. Edgil, T. G. Roberts, B. Lu, and E. Harris. 2000. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J. Virol. 74:7814-7823.
62. Ding, X., F. Xu, H. Chen, R. B. Tesh, and S. Y. Xiao. 2005. Apoptosis of hepatocytes caused by Punta Toro virus (Bunyaviridae: Phlebovirus) and its implication for Phlebovirus pathogenesis. Am. J. Pathol. 167:1043-1049.
63. Dong, T., E. Moran, N. Vinh Chau, C. Simmons, K. Luhn, Y. Peng, B. Wills, N. Phuong Dung, L. Thi Thu Thao, T. T. Hien, A. McMichael, J. Farrar, and S. Rowland-Jones. 2007. High pro-inflammatory cytokine secretion and loss of high avidity cross-reactive cytotoxic T-cells during the course of secondary dengue virus infection. PLoS One 2:e1192.
64. Durbin, A. P., M. J. Vargas, K. Wanionek, S. N. Hammond, A. Gordon, C. Rocha, A. Balmaseda, and E. Harris. 2008. Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology 376:429-435.
65. Esmon, C. T. 2005. The interactions between inflammation and coagulation. Br. J. Haematol. 131:417-430.
66. Espina, L. M., N. J. Valero, J. M. Hernandez, and J. A. Mosquera. 2003. Increased apoptosis and expression of tumor necrosis factor-alpha caused by infection of cultured human monocytes with dengue virus. Am. J. Trop. Med. Hyg. 68:48-53.
67. Esser, S., M. G. Lampugnani, M. Corada, E. Dejana, and W. Risau. 1998. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J. Cell Sci. 111:1853-1865. (Pubitemid 28141231)
68. Fabre, A., A. Couvelard, C. Degott, C. Lagorce-Pages, F. Bruneel, E. Bouvet, and F. Vachon. 2001. Dengue virus induced hepatitis with chronic calcific changes. Gut 49:864-865. (Pubitemid 33096047)
69. Falconar, A. K. 1997. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/ adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch. Virol. 142:897-916.
70. Feng, J. Q., K. Mozdzanowska, and W. Gerhard. 2002. Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype. J. Virol. 76:1369-1378.
71. Fernandez-Mestre, M. T., K. Gendzekhadze, P. Rivas-Vetencourt, and Z. Layrisse. 2004. TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 64: 469-472.
72. Frame, J. D. 1989. Clinical features of Lassa fever in Liberia. Rev. Infect. Dis. 11(Suppl. 4):S783-S789.
73. Fritz, R. S., F. G. Hayden, D. P. Calfee, L. M. Cass, A. W. Peng, W. G. Alvord, W. Strober, and S. E. Straus. 1999. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J. Infect. Dis. 180:586-593.
74. Gasperino, J., J. Yunen, A. Guh, K. E. Tanaka, V. Kvetan, and H. Doyle. 2007. Fulminant liver failure secondary to haemorrhagic dengue in an international traveller. Liver Int. 27:1148-1151. (Pubitemid 47399451)
75. Geisbert, T. W., and P. B. Jahrling. 2004. Exotic emerging viral diseases: progress and challenges. Nat. Med. 10:S110-S121.
76. Gentile, D., W. Doyle, T. Whiteside, P. Fireman, F. G. Hayden, and D. Skoner. 1998. Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection. Clin. Diagn. Lab. Immunol. 5:604-608.
77. Ghiasi, H., G. C. Perng, A. B. Nesburn, and S. L. Wechsler. 2000. Antibody-dependent enhancement of HSV-1 infection by anti-gK sera. Virus Res. 68:137-144. (Pubitemid 30665535)
78. Girn, J., M. Kavoosi, and J. Chantler. 2002. Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain. J. Gen. Virol. 83:351-358.
79. Graham, R. R., M. Juffrie, R. Tan, C. G. Hayes, I. Laksono, C. Ma'roef, Erlin, Sutaryo, K. R. Porter, and S. B. Halstead. 1999. A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996. Am. J. Trop. Med. Hyg. 61:412-419.
80. Guha-Sapir, D., and B. Schimmer. 2005. Dengue fever: new paradigms for a changing epidemiology. Emerg. Themes Epidemiol. 2:1.
81. Guilarde, A. O., M. D. Turchi, J. B. Siqueira, Jr., V. C. Feres, B. Rocha, J. E. Levi, V. A. Souza, L. S. Boas, C. S. Pannuti, and C. M. Martelli. 2008. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J. Infect. Dis. 197: 817-824.
82. Guirakhoo, F., S. Kitchener, D. Morrison, R. Forrat, K. McCarthy, R. Nichols, S. Yoksan, X. Duan, T. H. Ermak, N. Kanesa-Thasan, P. Bedford, J. Lang, M. J. Quentin-Millet, and T. P. Monath. 2006. Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. Hum. Vaccin. 2:60-67.
83. Guzman, M. G., M. Alvarez, R. Rodriguez, D. Rosario, S. Vazquez, L. Valds, M. V. Cabrera, and G. Kouri. 1999. Fatal dengue hemorrhagic fever in Cuba, 1997. Int. J. Infect. Dis. 3:130-135.
84. Guzman, M. G., and G. Kouri. 2003. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J. Clin. Virol. 27:1-13.
85. Guzman, M. G., G. Kouri, J. Bravo, L. Valdes, S. Vazquez, and S. B. Halstead. 2002. Effect of age on outcome of secondary dengue 2 infections. Int. J. Infect. Dis. 6:118-124.
86. Guzman, M. G., G. Kouri, and S. B. Halstead. 2000. Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics? Lancet 355:1902-1903.
87. Guzman, M. G., G. Kouri, L. Valdes, J. Bravo, M. Alvarez, S. Vazques, I. Delgado, and S. B. Halstead. 2000. Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am. J. Epidemiol. 152:793-799. (Discussion, 152: 804.)
88. Halstead, S. B. 2007. Dengue. Lancet. 370:1644-1652.
89. Halstead, S. B. 2006. Dengue in the Americas and Southeast Asia: do they differ? Rev. Panam. Salud Publica 20:407-415.
90. Halstead, S. B. 1970. Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J. Biol. Med. 42:350-362.
91. Halstead, S. B., S. Nimmannitya, and S. N. Cohen. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J. Biol. Med. 42:311-328.
92. Harris, E., E. Videa, L. Perez, E. Sandoval, Y. Tellez, M. L. Perez, R. Cuadra, J. Rocha, W. Idiaquez, R. E. Alonso, M. A. Delgado, L. A. Campo, F. Acevedo, A. Gonzalez, J. J. Amador, and A. Balmaseda. 2000. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am. J. Trop. Med. Hyg. 63:5-11.
93. Hayden, F. G., R. Fritz, M. C. Lobo, W. Alvord, W. Strober, and S. E. Straus. 1998. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Investig. 101:643-649.
94. Heller, M. V., M. C. Saavedra, R. Falcoff, J. I. Maiztegui, and F. C. Molinas. 1992. Increased tumor necrosis factor-alpha levels in Argentine hemorrhagic fever. J. Infect. Dis. 166:1203-1204.
95. Hjelm, F., F. Carlsson, A. Getahun, and B. Heyman. 2006. Antibodymediated regulation of the immune response. Scand. J. Immunol. 64:177-184.
96. Ho, L. J., M. F. Shaio, D. M. Chang, C. L. Liao, and J. H. Lai. 2004. Infection of human dendritic cells by dengue virus activates and primes T cells towards Th0-like phenotype producing both Th1 and Th2 cytokines. Immunol. Investig. 33:423-437.
97. Ho, L. J., J. J. Wang, M. F. Shaio, C. L. Kao, D. M. Chang, S. W. Han, and J. H. Lai. 2001. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 166:1499-1506.
98. Hober, D., W. Chehadeh, A. Bouzidi, and P. Wattre. 2001. Antibody-dependent enhancement of coxsackievirus B4 infectivity of human peripheral blood mononuclear cells results in increased interferon-alpha synthesis. J. Infect. Dis. 184:1098-1108.
99. Huang, Y. H., B. I. Chang, H. Y. Lei, H. S. Liu, C. C. Liu, H. L. Wu, and T. M. Yeh. 1997. Antibodies against dengue virus E protein peptide bind to human plasminogen and inhibit plasmin activity. Clin. Exp. Immunol. 110: 35-40.
100. Huang, Y. H., H. Y. Lei, H. S. Liu, Y. S. Lin, C. C. Liu, and T. M. Yeh. 2000. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am. J. Trop. Med. Hyg. 63:71-75.
101. Huerre, M. R., N. T. Lan, P. Marianneau, N. B. Hue, H. Khun, N. T. Hung, N. T. Khen, M. T. Drouet, V. T. Huong, D. Q. Ha, Y. Buisson, and V. Deubel. 2001. Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchows Arch. 438:107-115.
102. Huerta-Zepeda, A., C. Cabello-Gutierrez, J. Cime-Castillo, V. Monroy-Martinez, M. E. Manjarrez-Zavala, M. Gutierrez-Rodriguez, R. Izaguirre, and B. H. Ruiz-Ordaz. 2008. Crosstalk between coagulation and inflammation during dengue virus infection. Thromb. Haemost. 99:936-943.
103. Iankov, I. D., M. Pandey, M. Harvey, G. E. Griesmann, M. J. Federspiel, and S. J. Russell. 2006. Immunoglobulin G antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J. Virol. 80:8530-8540.
104. Imrie, A., J. Meeks, A. Gurary, M. Sukhbataar, P. Kitsutani, P. Effler, and Z. Zhao. 2007. Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes. J. Virol. 81:10081-10091. (Pubitemid 350067712)
105. Jassal, R., N. Jenkins, J. Charlwood, P. Camilleri, R. Jefferis, and J. Lund. 2001. Sialylation of human IgG-Fc carbohydrate by transfected rat alpha2,6-sialyltransferase. Biochem. Biophys. Res. Commun. 286:243-249.
106. Jessie, K., M. Y. Fong, S. Devi, S. K. Lam, and K. T. Wong. 2004. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J. Infect. Dis. 189:1411-1418.
107. Reference deleted.
108. Juffrie, M., G. M. Meer, C. E. Hack, K. Haasnoot, Sutaryo, A. J. Veerman, and L. G. Thijs. 2001. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am. J. Trop. Med. Hyg. 65:70-75.
109. Kangwanpong, D., N. Bhamarapravati, and H. L. Lucia. 1995. Diagnosing dengue virus infection in archived autopsy tissues by means of the in situ PCR method: a case report. Clin. Diagn. Virol. 3:165-172.
110. Kaplanski, G., B. Granel, T. Vaz, and J. M. Durand. 1998. Jarisch-Herxheimer reaction complicating the treatment of chronic Q. fever endocarditis: elevated TNFalpha and IL-6 serum levels. J. Infect. 37:83-84. (Pubitemid 28421218)
111. Killen, H., and M. A. O'Sullivan. 1993. Detection of dengue virus by in situ hybridization. J. Virol. Methods 41:135-146. (Pubitemid 23044114)
112. Kim, S. K., M. Cornberg, X. Z. Wang, H. D. Chen, L. K. Selin, and R. M. Welsh. 2005. Private specificities of CD8 T cell responses control patterns of heterologous immunity. J. Exp. Med. 201:523-533.
113. Kima, P. E., S. L. Constant, L. Hannum, M. Colmenares, K. S. Lee, A. M. Haberman, M. J. Shlomchik, and D. McMahon-Pratt. 2000. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 191:1063-1068.
114. Kittigul, L., P. Pitakarnjanakul, D. Sujirarat, and K. Siripanichgon. 2007. The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection. J. Clin. Virol. 39:76-81.
115. Klenerman, P., and R. M. Zinkernagel. 1998. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 394:482-485. (Pubitemid 28373959)
116. Kliks, S. C., S. Nimmanitya, A. Nisalak, and D. S. Burke. 1988. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 38:411-419.
117. Kliks, S. C., A. Nisalak, W. E. Brandt, L. Wahl, and D. S. Burke. 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40:444-451.
118. Koraka, P., S. Benton, G. van Amerongen, K. J. Stittelaar, and A. D. Osterhaus. 2007. Characterization of humoral and cellular immune responses in cynomolgus macaques upon primary and subsequent heterologous infections with dengue viruses. Microbes Infect. 9:940-946. (Pubitemid 46921016)
119. Koraka, P., S. Benton, G. van Amerongen, K. J. Stittelaar, and A. D. Osterhaus. 2007. Efficacy of a live attenuated tetravalent candidate dengue vaccine in naive and previously infected cynomolgus macaques. Vaccine 25:5409-5416. (Pubitemid 46977528)
120. Koraka, P., B. Murgue, X. Deparis, E. C. Van Gorp, T. E. Setiati, A. D. Osterhaus, and J. Groen. 2004. Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. J. Med. Virol. 72:445-450.
121. Koraka, P., C. Suharti, T. E. Setiati, A. T. Mairuhu, E. Van Gorp, C. E. Hack, M. Juffrie, J. Sutaryo, G. M. Van Der Meer, J. Groen, and A. D. Osterhaus. 2001. Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J. Clin. Microbiol. 39:4332-4338.
122. Kou, Z., M. Quinn, H. Chen, W. W. Rodrigo, R. C. Rose, J. J. Schlesinger, and X. Jin. 2008. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J. Med. Virol. 80:134-146.
123. Kouri, G. P., M. G. Guzman, and J. R. Bravo. 1987. Why dengue haemorrhagic fever in Cuba? 2. An integral analysis. Trans. R. Soc. Trop. Med. Hyg. 81:821-823.
124. Kouri, G. P., M. G. Guzman, J. R. Bravo, and C. Triana. 1989. Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull. W. H. O. 67:375-380.
125. Krishnamurti, C., and B. Alving. 1989. Effect of dengue virus on procoagulant and fibrinolytic activities of monocytes. Rev. Infect. Dis. 11 Suppl. 4:S843-S846.
126. Krishnamurti, C., S. Kalayanarooj, M. A. Cutting, R. A. Peat, S. W. Rothwell, T. J. Reid, S. Green, A. Nisalak, T. P. Endy, D. W. Vaughn, S. Nimmannitya, and B. L. Innis. 2001. Mechanisms of hemorrhage in dengue without circulatory collapse. Am. J. Trop. Med. Hyg. 65:840-847.
127. Kurosu, T., P. Chaichana, M. Yamate, S. Anantapreecha, and K. Ikuta. 2007. Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1. Biochem. Biophys. Res. Commun. 362: 1051-1056.
128. Kwan, W. H., A. M. Helt, C. Maranon, J. B. Barbaroux, A. Hosmalin, E. Harris, W. H. Fridman, and C. G. Mueller. 2005. Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection. J. Virol. 79:7291-7299. (Pubitemid 40756764)
129. Kyle, J. L., P. R. Beatty, and E. Harris. 2007. Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J. Infect. Dis. 195:1808-1817.
130. LaFleur, C., J. Granados, G. Vargas-Alarcon, J. Ruiz-Morales, C. Villarreal-Garza, L. Higuera, G. Hernandez-Pacheco, T. Cutino-Moguel, H. Rangel, R. Figueroa, M. Acosta, E. Lazcano, and C. Ramos. 2002. HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum. Immunol. 63:1039-1044.
131. Lancet. 1997. Dengue in the Americas - time to talk. Lancet 350:455.
132. Larroche, C., and L. Mouthon. 2004. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun. Rev. 3:69-75.
133. Laur, F., B. Murgue, X. Deparis, C. Roche, O. Cassar, and E. Chungue. 1998. Plasma levels of tumour necrosis factor alpha and transforming growth factor beta-1 in children with dengue 2 virus infection in French Polynesia. Trans. R. Soc. Trop. Med. Hyg. 92:654-656.
134. Lee, N., C. K. Wong, P. K. Chan, S. W. Lun, G. Lui, B. Wong, D. S. Hui, C. W. Lam, C. S. Cockram, K. W. Choi, A. C. Yeung, J. W. Tang, and J. J. Sung. 2007. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. Clin. Infect. Dis. 45:723-731.
135. Lee, Y. R., M. T. Liu, H. Y. Lei, C. C. Liu, J. M. Wu, Y. C. Tung, Y. S. Lin, T. M. Yeh, S. H. Chen, and H. S. Liu. 2006. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J. Gen. Virol. 87:3623-3630.
136. Leitmeyer, K. C., D. W. Vaughn, D. M. Watts, R. Salas, I. Villalobos, C. de, C. Ramos, and R. Rico-Hesse. 1999. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73:4738-4747.
137. Libraty, D. H., T. P. Endy, H. S. Houng, S. Green, S. Kalayanarooj, S. Suntayakorn, W. Chansiriwongs, D. W. Vaughn, A. Nisalak, F. A. Ennis, and A. L. Rothman. 2002. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J. Infect. Dis. 185:1213-1221.
138. Libraty, D. H., S. Pichyangkul, C. Ajariyakhajorn, T. P. Endy, and F. A. Ennis. 2001. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J. Virol. 75:3501-3508.
139. Libraty, D. H., P. R. Young, D. Pickering, T. P. Endy, S. Kalayanarooj, S. Green, D. W. Vaughn, A. Nisalak, F. A. Ennis, and A. L. Rothman. 2002. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J. Infect. Dis. 186:1165-1168.
140. Lidbury, B. A., and S. Mahalingam. 2000. Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection. J. Virol. 74:8376-8381.
141. Limon-Flores, A. Y., M. Perez-Tapia, I. Estrada-Garcia, G. Vaughan, A. Escobar-Gutierrez, J. Calderon-Amador, S. E. Herrera-Rodriguez, A. Brizuela-Garcia, M. Heras-Chavarria, A. Flores-Langarica, L. Cedillo-Barron, and L. Flores-Romo. 2005. Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int. J. Exp. Pathol. 86:323-334.
142. Limonta, D., V. Capo, G. Torres, A. B. Perez, and M. G. Guzman. 2007. Apoptosis in tissues from fatal dengue shock syndrome. J. Clin. Virol. 40:50-54.
143. Lin, C. F., S. C. Chiu, Y. L. Hsiao, S. W. Wan, H. Y. Lei, A. L. Shiau, H. S. Liu, T. M. Yeh, S. H. Chen, C. C. Liu, and Y. S. Lin. 2005. Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J. Immunol. 174:395-403.
144. Lin, C. F., H. Y. Lei, C. C. Liu, H. S. Liu, T. M. Yeh, S. T. Wang, T. I. Yang, F. C. Sheu, C. F. Kuo, and Y. S. Lin. 2001. Generation of IgM anti-platelet autoantibody in dengue patients. J. Med. Virol. 63:143-149.
145. Lin, C. F., H. Y. Lei, A. L. Shiau, C. C. Liu, H. S. Liu, T. M. Yeh, S. H. Chen, and Y. S. Lin. 2003. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J. Med. Virol. 69:82-90.
146. Lin, C. F., H. Y. Lei, A. L. Shiau, H. S. Liu, T. M. Yeh, S. H. Chen, C. C. Liu, S. C. Chiu, and Y. S. Lin. 2002. Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. J. Immunol. 169:657-664.
147. Lin, C. F., S. W. Wan, M. C. Chen, S. C. Lin, C. C. Cheng, S. C. Chiu, Y. L. Hsiao, H. Y. Lei, H. S. Liu, T. M. Yeh, and Y. S. Lin. 2008. Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model. Lab. Investig. 88:1079-1089.
148. Loke, H., D. Bethell, C. X. Phuong, N. Day, N. White, J. Farrar, and A. Hill. 2002. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. Am. J. Trop. Med. Hyg. 67:102-106.
149. Loke, H., D. B. Bethell, C. X. Phuong, M. Dung, J. Schneider, N. J. White, N. P. Day, J. Farrar, and A. V. Hill. 2001. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J. Infect. Dis. 184:1369-1373.
150. Luplertlop, N., D. Misse, D. Bray, V. Deleuze, J. P. Gonzalez, V. Leardkamolkarn, H. Yssel, and F. Veas. 2006. Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Rep. 7:1176-1181.
151. Ma, H., and J. A. Kapp. 2000. Antigenic epitopes regulate the phenotype of CD8+ CTL primed by exogenous antigens. J. Immunol. 164:5698-5703. (Pubitemid 30389811)
152. Ma, H., and J. A. Kapp. 2001. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo. Cell. Immunol. 214:89-96.
153. Mabalirajan, U., T. Kadhiravan, S. K. Sharma, A. Banga, and B. Ghosh. 2005. Th(2) immune response in patients with dengue during defervescence: preliminary evidence. Am. J. Trop. Med. Hyg. 72:783-785.
154. Reference deleted.
155. Mahalingam, S., and B. A. Lidbury. 2003. Antibody-dependent enhancement of infection: bacteria do it too. Trends Immunol. 24:465-467. (Pubitemid 37088145)
156. Mahalingam, S., and B. A. Lidbury. 2002. Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus. Proc. Natl. Acad. Sci. USA 99:13819-13824.
157. Mairuhu, A. T., M. R. Mac Gillavry, T. E. Setiati, A. Soemantri, H. ten Cate, D. P. Brandjes, and E. C. van Gorp. 2003. Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. Lancet Infect. Dis. 3:33-41.
158. Mairuhu, A. T., T. E. Setiati, P. Koraka, C. E. Hack, A. Leyte, S. M. Faradz, C. H. ten, D. P. Brandjes, A. D. Osterhaus, P. H. Reitsma, and E. C. van Gorp. 2005. Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism. Thromb. J. 3:17.
159. Mangada, M. M., T. P. Endy, A. Nisalak, S. Chunsuttiwat, D. W. Vaughn, D. H. Libraty, S. Green, F. A. Ennis, and A. L. Rothman. 2002. Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J. Infect. Dis. 185:1697-1703.
160. Marchette, N. J., and S. B. Halstead. 1973. Survival of dengue virus in post mortem samples of tissues from experimentally infected rhesus monkeys. Am. J. Trop. Med. Hyg. 22:242-243.
161. Marchette, N. J., S. B. Halstead, W. A. Falkler, Jr., A. Stenhouse, and D. Nash. 1973. Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. J. Infect. Dis. 128:23-30.
162. Marchette, N. J., S. B. Halstead, D. R. Nash, and A. C. Stenhouse. 1972. Recovery of dengue viruses from tissues of experimentally infected rhesus monkeys. Appl. Microbiol. 24:328-333.
163. Markiewski, M. M., B. Nilsson, K. N. Ekdahl, T. E. Mollnes, and J. D. Lambris. 2007. Complement and coagulation: strangers or partners in crime? Trends Immunol. 28:184-192.
164. Markoff, L. J., B. L. Innis, R. Houghten, and L. S. Henchal. 1991. Development of cross-reactive antibodies to plasminogen during the immune response to dengue virus infection. J. Infect. Dis. 164:294-301.
165. Marta, R. F., V. S. Montero, C. E. Hack, A. Sturk, J. I. Maiztegui, and F. C. Molinas. 1999. Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg. 60:85-89.
166. Mathew, A., I. Kurane, S. Green, D. W. Vaughn, S. Kalayanarooj, S. Suntayakorn, F. A. Ennis, and A. L. Rothman. 1999. Impaired T cell proliferation in acute dengue infection. J. Immunol. 162:5609-5615. (Pubitemid 29307175)
167. Medin, C. L., K. A. Fitzgerald, and A. L. Rothman. 2005. Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion. J. Virol. 79:11053-11061.
168. Mehlhop, E., C. Ansarah-Sobrinho, S. Johnson, M. Engle, D. H. Fremont, T. C. Pierson, and M. S. Diamond. 2007. Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Cell Host Microbes 2:417-426. (Pubitemid 350215325)
169. Miagostovich, M. P., R. G. Ramos, A. F. Nicol, R. M. Nogueira, T. Cuzzi-Maya, A. V. Oliveira, R. S. Marchevsky, R. P. Mesquita, and H. G. Schatzmayr. 1997. Retrospective study on dengue fatal cases. Clin. Neuropathol. 16:204-208.
170. Mongkolsapaya, J., W. Dejnirattisai, X. N. Xu, S. Vasanawathana, N. Tangthawornchaikul, A. Chairunsri, S. Sawasdivorn, T. Duangchinda, T. Dong, S. Rowland-Jones, P. T. Yenchitsomanus, A. McMichael, P. Malasit, and G. Screaton. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9:921-927.
171. Mongkolsapaya, J., T. Duangchinda, W. Dejnirattisai, S. Vasanawathana, P. Avirutnan, A. Jairungsri, N. Khemnu, N. Tangthawornchaikul, P. Chotiyarnwong, K. Sae-Jang, M. Koch, Y. Jones, A. McMichael, X. Xu, P. Malasit, and G. Screaton. 2006. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? J. Immunol. 176:3821-3829. (Pubitemid 43364031)
172. Morel, J. C., C. C. Park, J. M. Woods, and A. E. Koch. 2001. A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. J. Biol. Chem. 276:37069-37075.
173. Murgue, B., O. Cassar, and X. Deparis. 2001. Plasma concentrations of sVCAM-1 and severity of dengue infections. J. Med. Virol. 65:97-104.
174. Mustafa, A. S., E. A. Elbishbishi, R. Agarwal, and U. C. Chaturvedi. 2001. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol. Med. Microbiol. 30:229-233.
175. Nachman, R. L., and S. Rafii. 2008. Platelets, petechiae, and preservation of the vascular wall. N. Engl. J. Med. 359:1261-1270.
176. Nakao, S., C. J. Lai, and N. S. Young. 1989. Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood 74:1235-1240. (Pubitemid 19227429)
177. Nguyen, T. H., H. Y. Lei, T. L. Nguyen, Y. S. Lin, K. J. Huang, B. L. Le, C. F. Lin, T. M. Yeh, Q. H. Do, T. Q. Vu, L. C. Chen, J. H. Huang, T. M. Lam, C. C. Liu, and S. B. Halstead. 2004. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J. Infect. Dis. 189:221-232.
178. Nisalak, A., S. B. Halstead, P. Singharaj, S. Udomsakdi, S. W. Nye, and K. Vinijchaikul. 1970. Observations related to pathogenesis of dengue hemorrhagic fever. 3. Virologic studies of fatal disease. Yale J. Biol. Med. 42:293-310.
179. Nishioka, K. 1974. Serum complement level in dengue hemorrhagic fever. Allerg. Immunol. (Leipz) 21:385-392.
180. Nkhoma, E. T., C. Poole, V. Vannappagari, S. A. Hall, and E. Beutler. 2009. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol. Dis. 42:267-278.
181. Ogawa, Y., and J. A. Grant. 2007. Mediators of anaphylaxis. Immunol. Allergy Clin. N. Am. 27:249-260, vii.
182. Oishi, K., S. Inoue, M. T. Cinco, E. M. Dimaano, M. T. Alera, J. A. Alfon, F. Abanes, D. J. Cruz, R. R. Matias, H. Matsuura, F. Hasebe, S. Tanimura, A. Kumatori, K. Morita, F. F. Natividad, and T. Nagatake. 2003. Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections. J. Med. Virol. 71:259-264.
183. Ong, A., M. Sandar, M. I. Chen, and L. Y. Sin. 2007. Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore. Int. J. Infect. Dis. 11:263-267.
184. Reference deleted.
185. Padigel, U. M., and J. P. Farrell. 2005. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells. J. Immunol. 174:6340-6345.
186. Paes, M. V., A. T. Pinhao, D. F. Barreto, S. M. Costa, M. P. Oliveira, A. C. Nogueira, C. M. Takiya, J. C. Farias-Filho, H. G. Schatzmayr, A. M. Alves, and O. M. Barth. 2005. Liver injury and viremia in mice infected with dengue-2 virus. Virology 338:236-246.
187. Palmer, D. R., P. Sun, C. Celluzzi, J. Bisbing, S. Pang, W. Sun, M. A. Marovich, and T. Burgess. 2005. Differential effects of dengue virus on infected and bystander dendritic cells. J. Virol. 79:2432-2439.
188. Perez, A. B., G. Garcia, B. Sierra, M. Alvarez, S. Vazquez, M. V. Cabrera, R. Rodriguez, D. Rosario, E. Martinez, T. Denny, and M. G. Guzman. 2004. IL-10 levels in dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J. Med. Virol. 73:230-234.
189. Peyrefitte, C. N., B. Pastorino, G. E. Grau, J. Lou, H. Tolou, and P. Couissinier-Paris. 2006. Dengue virus infection of human microvascular endothelial cells from different vascular beds promotes both common and specific functional changes. J. Med. Virol. 78:229-242.
190. Picard, C., J. L. Casanova, and L. Abel. 2006. Mendelian traits that confer predisposition or resistance to specific infections in humans. Curr. Opin. Immunol. 18:383-390.
191. Pinheiro, F. P., and S. J. Corber. 1997. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Stat. Q. 50:161-169.
192. Polizel, J. R., D. Bueno, J. E. Visentainer, A. M. Sell, S. D. Borelli, L. T. Tsuneto, M. M. Dalalio, M. T. Coimbra, and R. A. Moliterno. 2004. Association of human leukocyte antigen DQ1 and dengue fever in a white Southern Brazilian population. Mem. Inst. Oswaldo Cruz 99:559-562.
193. Pongsumpun, P., S. Yoksan, and I. M. Tan. 2002. A comparison of the age distributions in the dengue hemorrhagic fever epidemics in Santiago de Cuba (1997) and Thailand (1998). Southeast Asian J. Trop. Med. Public Health 33:255-258.
194. Ponnuraj, E. M., J. Springer, A. R. Hayward, H. Wilson, and E. A. Simoes. 2003. Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model. J. Infect. Dis. 187:1257-1263.
195. Quaresma, J. A., V. L. Barros, C. Pagliari, E. R. Fernandes, H. F. Andrade, Jr., P. F. Vasconcelos, and M. I. Duarte. 2007. Hepatocyte lesions and cellular immune response in yellow fever infection. Trans. R. Soc. Trop. Med. Hyg. 101:161-168.
196. Quaresma, J. A., V. L. Barros, C. Pagliari, E. R. Fernandes, F. Guedes, C. F. Takakura, H. F. Andrade, Jr., P. F. Vasconcelos, and M. I. Duarte. 2006. Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity. Virology. 345:22-30.
197. Raghupathy, R., U. C. Chaturvedi, H. Al-Sayer, E. A. Elbishbishi, R. Agarwal, R. Nagar, S. Kapoor, A. Misra, A. Mathur, H. Nusrat, F. Azizieh, M. A. Khan, and A. S. Mustafa. 1998. Elevated levels of IL-8 in dengue hemorrhagic fever. J. Med. Virol. 56:280-285.
198. Ravelli, A. 2002. Macrophage activation syndrome. Curr. Opin. Rheumatol. 14:548-552.
199. Restrepo, B. N., D. M. Isaza, C. L. Salazar, R. Ramirez, M. Ospina, and L. G. Alvarez. 2008. Serum levels of interleukin-6, tumor necrosis factor-alpha and interferon-gamma in infants with and without dengue. Rev. Soc. Bras. Med. Trop. 41:6-10.
200. Rico-Hesse, R. 1990. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology 174:479-493. (Pubitemid 20060152)
201. Rico-Hesse, R., L. M. Harrison, A. Nisalak, D. W. Vaughn, S. Kalayanarooj, S. Green, A. L. Rothman, and F. A. Ennis. 1998. Molecular evolution of dengue type 2 virus in Thailand. Am. J. Trop. Med. Hyg. 58:96-101.
202. Rico-Hesse, R., L. M. Harrison, R. A. Salas, D. Tovar, A. Nisalak, C. Ramos, J. Boshell, M. T. de Mesa, R. M. Nogueira, and A. T. da Rosa. 1997. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230:244-251. (Pubitemid 27211855)
203. Rodriguez-Roche, R., M. Alvarez, T. Gritsun, S. Halstead, G. Kouri, E. A. Gould, and M. G. Guzman. 2005. Virus evolution during a severe dengue epidemic in Cuba, 1997. Virology 334:154-159.
204. Rosen, L., M. T. Drouet, and V. Deubel. 1999. Detection of dengue virus RNA by reverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection. Am. J. Trop. Med. Hyg. 61:720-724.
205. Rosenberg, R. D. 2001. Vascular-bed-specific hemostasis and hypercoagulable states: clinical utility of activation peptide assays in predicting thrombotic events in different clinical populations. Thromb. Haemost. 86:41-50.
206. Rosenberg, R. D., and W. C. Aird. 1999. Vascular-bed-specific hemostasis and hypercoagulable states. N. Engl. J. Med. 340:1555-1564.
207. Rothwell, S. W., R. Putnak, and V. F. La Russa. 1996. Dengue-2 virus infection of human bone marrow: characterization of dengue-2 antigen-positive stromal cells. Am. J. Trop. Med. Hyg. 54:503-510.
208. Sahaphong, S., S. Riengrojpitak, N. Bhamarapravati, and T. Chirachariyavej. 1980. Electron microscopic study of the vascular endothelial cell in dengue hemorrhagic fever. Southeast Asian J. Trop. Med. Public Health 11:194-204.
209. Saito, M., K. Oishi, S. Inoue, E. M. Dimaano, M. T. Alera, A. M. Robles, B. D. Estrella, Jr., A. Kumatori, K. Moji, M. T. Alonzo, C. C. Buerano, R. R. Matias, K. Morita, F. F. Natividad, and T. Nagatake. 2004. Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin. Exp. Immunol. 138:299-303.
210. Sakuntabhai, A., C. Turbpaiboon, I. Casademont, A. Chuansumrit, T. Lowhnoo, A. Kajaste-Rudnitski, S. M. Kalayanarooj, K. Tangnararatchakit, N. Tangthawornchaikul, S. Vasanawathana, W. Chaiyaratana, P. T. Yenchitsomanus, P. Suriyaphol, P. Avirutnan, K. Chokephaibulkit, F. Matsuda, S. Yoksan, Y. Jacob, G. M. Lathrop, P. Malasit, P. Despres, and C. Julier. 2005. A variant in the CD209 promoter is associated with severity of dengue disease. Nat. Genet. 37:507-513.
211. Sanchez, I. J., and B. H. Ruiz. 1996. A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain affects neurovirulence in mice. J. Gen. Virol. 77:2541-2545.
212. Sangkawibha, N., S. Rojanasuphot, S. Ahandrik, S. Viriyapongse, S. Jatanasen, V. Salitul, B. Phanthumachinda, and S. B. Halstead. 1984. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120:653-669.
213. Sariol, C. A., J. L. Pelegrino, A. Martinez, E. Arteaga, G. Kouri, and M. G. Guzman. 1999. Detection and genetic relationship of dengue virus sequences in seventeen-year-old paraffin-embedded samples from Cuba. Am. J. Trop. Med. Hyg. 61:994-1000.
214. Selin, L. K., M. A. Brehm, Y. N. Naumov, M. Cornberg, S. K. Kim, S. C. Clute, and R. M. Welsh. 2006. Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol. Rev. 211:164-181.
215. Selin, L. K., M. Cornberg, M. A. Brehm, S. K. Kim, C. Calcagno, D. Ghersi, R. Puzone, F. Celada, and R. M. Welsh. 2004. CD8 memory T cells: cross-reactivity and heterologous immunity. Semin. Immunol. 16:335-347.
216. Selin, L. K., S. M. Varga, I. C. Wong, and R. M. Welsh. 1998. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 188:1705-1715.
217. Seneviratne, S. L., G. N. Malavige, and H. J. de Silva. 2006. Pathogenesis of liver involvement during dengue viral infections. Trans. R. Soc. Trop. Med. Hyg. 100:608-614.
218. Setiati, T. E., A. T. Mairuhu, P. Koraka, M. Supriatna, M. R. Mac Gillavry, D. P. Brandjes, A. D. Osterhaus, J. W. van der Meer, E. C. van Gorp, and A. Soemantri. 2007. Dengue disease severity in Indonesian children: an evaluation of the World Health Organization classification system. BMC Infect. Dis. 7:22.
219. Shaio, M. F., F. Y. Chang, and S. C. Hou. 1992. Complement pathway activity in serum from patients with classical dengue fever. Trans. R. Soc. Trop. Med. Hyg. 86:672-675.
220. Sharma, J. N., A. Al-Omran, and S. S. Parvathy. 2007. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 15:252-259. (Pubitemid 351196133)
221. Shen, B. Q., D. Y. Lee, K. M. Cortopassi, L. A. Damico, and T. F. Zioncheck. 2001. Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells. J. Biol. Chem. 276:5281-5286.
222. Shresta, S., K. L. Sharar, D. M. Prigozhin, P. R. Beatty, and E. Harris. 2006. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J. Virol. 80:10208-10217. (Pubitemid 44522614)
223. Shu, P. Y., L. K. Chen, S. F. Chang, Y. Y. Yueh, L. Chow, L. J. Chien, C. Chin, T. H. Lin, and J. H. Huang. 2000. Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever. J. Med. Virol. 62:224-232.
224. Reference deleted.
225. Reference deleted.
226. Simmons, C. P., T. N. Chau, T. T. Thuy, N. M. Tuan, D. M. Hoang, N. T. Thien, B. Lien le, N. T. Quy, N. T. Hieu, T. T. Hien, C. McElnea, P. Young, S. Whitehead, N. T. Hung, and J. Farrar. 2007. Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J. Infect. Dis. 196: 416-424.
227. Snyder, J. T., M. A. Alexander-Miller, J. A. Berzofskyl, and I. M. Belyakov. 2003. Molecular mechanisms and biological significance of CTL avidity. Curr. HIV Res. 1:287-294.
228. Sosothikul, D., P. Seksarn, S. Pongsewalak, U. Thisyakorn, and J. Lusher. 2007. Activation of endothelial cells, coagulation and fibrinolysis in children with dengue virus infection. Thromb. Haemost. 97:627-634.
229. Soundravally, R., and S. L. Hoti. 2007. Immunopathogenesis of dengue hemorrhagic fever and shock syndrome: role of TAP and HPA gene polymorphism. Hum. Immunol. 68:973-979.
230. Soundravally, R., and S. L. Hoti. 2008. Polymorphisms of the TAP 1 and 2 gene may influence clinical outcome of primary dengue viral infection. Scand. J. Immunol. 67:618-625.
231. Reference deleted.
232. Sreedharan, A., S. Bowyer, C. A. Wallace, M. J. Robertson, K. Schmidt, A. E. Woolfrey, and R. P. Nelson, Jr. 2006. Macrophage activation syndrome and other systemic inflammatory conditions after BMT. Bone Marrow Transplant. 37:629-634.
233. Srichaikul, T., and S. Nimmannitya. 2000. Haematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract. Res. Clin. Haematol. 13:261-276.
234. Srikiatkhachorn, A., C. Ajariyakhajorn, T. P. Endy, S. Kalayanarooj, D. H. Libraty, S. Green, F. A. Ennis, and A. L. Rothman. 2007. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic fever. J. Virol. 81:1592-1600. (Pubitemid 46214434)
235. Srikiatkhachorn, A., A. Krautrachue, W. Ratanaprakarn, L. Wongtapradit, N. Nithipanya, S. Kalayanarooj, A. Nisalak, S. J. Thomas, R. V. Gibbons, M. P. Mammen, Jr., D. H. Libraty, F. A. Ennis, A. L. Rothman, and S. Green. 2007. Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study. Pediatr. Infect. Dis. J. 26:283-290. (Discussion, 26:291-292.)
236. Stamatovic, S. M., R. F. Keep, S. L. Kunkel, and A. V. Andjelkovic. 2003. Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J. Cell Sci. 116:4615-4628.
237. Stephens, H. A., R. Klaythong, M. Sirikong, D. W. Vaughn, S. Green, S. Kalayanarooj, T. P. Endy, D. H. Libraty, A. Nisalak, B. L. Innis, A. L. Rothman, F. A. Ennis, and D. Chandanayingyong. 2002. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60:309-318.
238. Strait, R., S. C. Morrist, and F. D. Finkelman. 2004. Cytokine enhancement of anaphylaxis. Novartis Found Symp 257:80-91. (Discussion, 257:91-100, 276-285.)
239. Streatfield, R., G. Bielby, and D. Sinclair. 1993. A primary dengue 2 epidemic with spontaneous haemorrhagic manifestations. Lancet 342:560-561. (Pubitemid 23259216)
240. Subbramanian, R. A., J. Xu, E. Toma, R. Morisset, E. A. Cohen, J. Menezes, and A. Ahmad. 2002. Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients. J. Clin. Microbiol. 40:2141-2146.
241. Suharti, C., E. C. van Gorp, T. E. Setiati, W. M. Dolmans, R. J. Djokomoeljanto, C. E. Hack, C. H. ten, and J. W. van der Meer. 2002. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome. Thromb. Haemost. 87:42-46.
242. Sun, D. S., C. C. King, H. S. Huang, Y. L. Shih, C. C. Lee, W. J. Tsai, C. C. Yu, and H. H. Chang. 2007. Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. J. Thromb. Haemost. 5:2291-2299.
243. Takada, A., H. Feldmann, T. G. Ksiazek, and Y. Kawaoka. 2003. Antibody-dependent enhancement of Ebola virus infection. J. Virol. 77:7539-7544. (Pubitemid 36734524)
244. Takhampunya, R., R. Padmanabhan, and S. Ubol. 2006. Antiviral action of nitric oxide on dengue virus type 2 replication. J. Gen. Virol. 87:3003-3011.
245. Tamura, M., R. G. Webster, and F. A. Ennis. 1994. Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses. J. Virol. 68:3499-3504. (Pubitemid 24177373)
246. ter Meulen, J., M. Sakho, K. Koulemou, N. Magassouba, A. Bah, W. Preiser, S. Daffis, C. Klewitz, H. G. Bae, M. Niedrig, H. Zeller, M. Heinzel-Gutenbrunner, L. Koivogui, and A. Kaufmann. 2004. Activation of the cytokine network and unfavorable outcome in patients with yellow fever. J. Infect. Dis. 190:1821-1827.
247. Thein, S., J. Aaskov, T. T. Myint, T. N. Shwe, T. T. Saw, and A. Zaw. 1993. Changes in levels of anti-dengue virus IgG subclasses in patients with disease of varying severity. J. Med. Virol. 40:102-106.
248. Thiel, S., P. D. Frederiksen, and J. C. Jensenius. 2006. Clinical manifestations of mannan-binding lectin deficiency. Mol. Immunol. 43:86-96.
249. Thomas, B. N., and L. U. Buxbaum. 2008. FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions. Infect. Immun. 76:623-631.
250. Thomas, L., O. Verlaeten, A. Cabie, S. Kaidomar, V. Moravie, J. Martial, F. Najioullah, Y. Plumelle, C. Fonteau, P. Dussart, and R. Cesaire. 2008. Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic. Am. J. Trop. Med. Hyg. 78:990-998.
251. Thulkar, S., S. Sharma, D. N. Srivastava, S. K. Sharma, M. Berry, and R. M. Pandey. 2000. Sonographic findings in grade III dengue hemorrhagic fever in adults. J. Clin. Ultrasound. 28:34-37.
252. To, K. F., P. K. Chan, K. F. Chan, W. K. Lee, W. Y. Lam, K. F. Wong, N. L. Tang, D. N. Tsang, R. Y. Sung, T. A. Buckley, J. S. Tam, and A. F. Cheng. 2001. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J. Med. Virol. 63:242-246.
253. Ubol, S., T. Chareonsirisuthigul, J. Kasisith, and C. Klungthong. 2008. Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells. Virology 376:290-296.
254. Ubol, S., P. Masrinoul, J. Chaijaruwanich, S. Kalayanarooj, T. Charoensirisuthikul, and J. Kasisith. 2008. Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever. J. Infect. Dis. 197:1459-1467.
255. Urbani, S., B. Amadei, P. Fisicaro, M. Pilli, G. Missale, A. Bertoletti, and C. Ferrari. 2005. Heterologous T cell immunity in severe hepatitis C virus infection. J. Exp. Med. 201:675-680.
256. Vaughn, D. W., S. Green, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, T. P. Endy, B. Raengsakulrach, A. L. Rothman, F. A. Ennis, and A. Nisalak. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181:2-9.
257. Venkata Sai, P. M., B. Dev, and R. Krishnan. 2005. Role of ultrasound in dengue fever. Br. J. Radiol 78:416-418.
258. Villinger, F., P. E. Rollin, S. S. Brar, N. F. Chikkala, J. Winter, J. B. Sundstrom, S. R. Zaki, R. Swanepoel, A. A. Ansari, and C. J. Peters. 1999. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J. Infect. Dis. 179(Suppl. 1):S188-S191.
259. Wahid, S. F., S. Sanusi, M. M. Zawawi, and R. A. Ali. 2000. A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. Southeast Asian J. Trop. Med. Public Health 31:259-263.
260. Wallace, M. J., D. W. Smith, A. K. Broom, J. S. Mackenzie, R. A. Hall, G. R. Shellam, and P. C. McMinn. 2003. Antibody-dependent enhancement of Murray Valley encephalitis virus virulence in mice. J. Gen. Virol. 84:1723-1728.
261. Wang, C. C., C. C. Wu, J. W. Liu, A. S. Lin, S. F. Liu, Y. H. Chung, M. C. Su, I. K. Lee, and M. C. Lin. 2007. Chest radiographic presentation in patients with dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 77:291-296.
262. Wang, L., and S. M. Dudek. 2009. Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc. Res. 77:39-45.
263. Wang, W. K., D. Y. Chao, C. L. Kao, H. C. Wu, Y. C. Liu, C. M. Li, S. C. Lin, S. T. Ho, J. H. Huang, and C. C. King. 2003. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology 305:330-338.
264. Wang, W. K., H. L. Chen, C. F. Yang, S. C. Hsieh, C. C. Juan, S. M. Chang, C. C. Yu, L. H. Lin, J. H. Huang, and C. C. King. 2006. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin. Infect. Dis. 43:1023-1030.
265. Wedemeyer, H., E. Mizukoshi, A. R. Davis, J. R. Bennink, and B. Rehermann. 2001. Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. J. Virol. 75:11392-11400. (Pubitemid 33063230)
266. Wichmann, O., J. Gascon, M. Schunk, S. Puente, H. Siikamaki, I. Gjorup, R. Lopez-Velez, J. Clerinx, G. Peyerl-Hoffmann, A. Sundoy, B. Genton, P. Kern, G. Calleri, M. de Gorgolas, N. Muhlberger, T. Jelinek, and the European Network on Surveillance of Imported Infectious Diseases. 2007. Severe dengue virus infection in travelers: risk factors and laboratory indicators. J. Infect. Dis. 195:1089-1096.
267. Wills, B. A., E. E. Oragui, A. C. Stephens, O. A. Daramola, N. M. Dung, H. T. Loan, N. V. Chau, M. Chambers, K. Stepniewska, J. J. Farrar, and M. Levin. 2002. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin. Infect. Dis. 35:277-285.
268. World Health Organization. 1997. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control, 2nd ed. WHO, Geneva, Switzerland.
269. Wu, S. J., G. Grouard-Vogel, W. Sun, J. R. Mascola, E. Brachtel, R. Putvatana, M. K. Louder, L. Filgueira, M. A. Marovich, H. K. Wong, A. Blauvelt, G. S. Murphy, M. L. Robb, B. L. Innes, D. L. Birx, C. G. Hayes, and S. S. Frankel. 2000. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6:816-820.
270. Wu, Y. H., C. P. Tseng, M. L. Cheng, H. Y. Ho, S. R. Shih, and D. T. Chiu. 2008. Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection. J. Infect. Dis. 197:812-816.
271. Yamada, M., S. Kim, K. Egashira, M. Takeya, T. Ikeda, O. Mimura, and H. Iwao. 2003. Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 23:1996-2001.
272. Yamanaka, A., S. Kosugi, and E. Konishi. 2008. Infection-enhancing and -neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels. J. Virol. 82:927-937.
273. Yauch, L. E., and S. Shresta. 2008. Mouse models of dengue virus infection and disease. Antivir. Res. 80:87-93.
274. Yuen, K. Y., P. K. Chan, M. Peiris, D. N. Tsang, T. L. Que, K. F. Shortridge, P. T. Cheung, W. K. To, E. T. Ho, R. Sung, and A. F. Cheng. 1998. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351:467-471.
275. Zampieri, C. A., N. J. Sullivan, and G. J. Nabel. 2007. Immunopathology of highly virulent pathogens: insights from Ebola virus. Nat. Immunol. 8:1159-1164.
276. Zivna, I., S. Green, D. W. Vaughn, S. Kalayanarooj, H. A. Stephens, D. Chandanayingyong, A. Nisalak, F. A. Ennis, and A. L. Rothman. 2002. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J. Immunol. 168:5959-5965. (Pubitemid 34556187)